Skip to main content

Table 2 Clinical and Pathologic Characteristics of Patients (n = 46)

From: MRI evaluation of vesical imaging reporting and data system for bladder cancer after neoadjuvant chemotherapy

Characteristics

MIBC (n = 21)

NMIBC (n = 25)

Age, year

Mean ± Standard Deviation

63 ± 9

60 ± 10

Range

45–77

29–72

Gender

 Male

20 (95)

22 (88)

 Female

1 (5)

3 (12)

Number of lesions

 Solitary

19 (90.0)

13 (52)

 Multiple

2 (10.0)

12 (48)

Submucosal Linear Enhancement

 Yes

4 (19)

7 (28)

 No

17 (81)

18 (72)

Primary or recurrent tumors

 Primary

16 (76)

21 (84)

 Recurrent

5 (24)

4 (16)

Histologic grade

 Low grade

3 (14)

6 (24)

 High grade

18 (86)

19 (76)

NAC cycles

 2

5 (23.8)

7 (28)

 3

10 (47.6)

11 (44)

 4

6 (28.6)

7 (28)

Treatment method

 NAC + Radical cystectomy

13 (62)

5 (20)

 NAC + Partial cystectomy

3 (14)

1 (4)

 NAC + TURBT

5(24)

19 (76)

  1. Numbers in parentheses are percentages
  2. TURBT Transurethral resection of bladder tumor, MIBC Muscle-invasive bladder cancer, NAC Neoadjuvant chemotherapy, NMIBC Non–muscle-invasive bladder cancer